首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors.
【2h】

Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors.

机译:代谢型谷氨酸受体刺激淀粉样前体蛋白的加工。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Stimulation of muscarinic m1 or m3 receptors can, by generating diacylglycerol and activating protein kinase C, accelerate the breakdown of the amyloid precursor protein (APP) to form soluble, nonamyloidogenic derivatives (APPs), as previously shown. This relationship has been demonstrated in human glioma and neuroblastoma cells, as well as in transfected human embryonic kidney 293 cells and PC-12 cells. We now provide evidence that stimulation of metabotropic glutamate receptors (mGluRs), which also are coupled to phosphatidylinositol 4,5-bisphosphate hydrolysis, similarly accelerates processing of APP into nonamyloidogenic APPs. This process is demonstrated both in hippocampal neurons derived from fetal rats and in human embryonic kidney 293 cells transfected with cDNA expression constructs encoding the mGluR 1 alpha subtype. In hippocampal neurons, both an mGluR antagonist, L-(+)-2-amino-3-phosphonopropionic acid, and an inhibitor of protein kinase C, GF 109203X, blocked the APPs release evoked by glutamate receptor stimulation. Ionotropic glutamate agonists, N-methyl-D-aspartate or S(-)-5-fluorowillardiine, failed to affect APPs release. These data show that selective mGluR agonists that initiate signal-transduction events can regulate APP processing in bona fide primary neurons and transfected cells. As glutamatergic neurons in the cortex and hippocampus are damaged in Alzheimer disease, amyloid production in these regions may be enhanced by deficits in glutamatergic neurotransmission.
机译:如前所述,刺激毒蕈碱型m1或m3受体可以通过产生二酰基甘油并激活蛋白激酶C来加速淀粉样前体蛋白(APP)的分解,形成可溶的,非淀粉样生成的衍生物(APPs)。已经在人神经胶质瘤和神经母细胞瘤细胞以及转染的人胚胎肾293细胞和PC-12细胞中证明了这种关系。现在,我们提供的证据表明,促代谢谷氨酸受体(mGluRs)的刺激(也与磷脂酰肌醇4,5-双磷酸酯水解反应耦合)同样会加速APP转化为非淀粉样的APP。在衍生自胎鼠的海马神经元和用编码mGluR 1 alpha亚型的cDNA表达构建体转染的人胚肾293细胞中均证实了该过程。在海马神经元中,mGluR拮抗剂L-(+)-2-氨基-3-膦酰丙酸和蛋白激酶C抑制剂GF 109203X均能阻止谷氨酸受体刺激引起的APP释放。离子型谷氨酸激动剂,N-甲基-D-天冬氨酸或S(-)-5-氟柳丁碱不能影响APP的释放。这些数据表明,启动信号转导事件的选择性mGluR激动剂可以调节真正的原代神经元和转染细胞中的APP处理。由于阿尔茨海默氏病会损害皮质和海马中的谷氨酸能神经元,因此谷氨酸能神经传递的不足可能会增强这些区域的淀粉样蛋白产生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号